Correlation Between Spyre Therapeutics and Datadog

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Datadog at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Datadog into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spyre Therapeutics and Datadog, you can compare the effects of market volatilities on Spyre Therapeutics and Datadog and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Datadog. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Datadog.

Diversification Opportunities for Spyre Therapeutics and Datadog

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between Spyre and Datadog is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Datadog in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Datadog and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Datadog. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Datadog has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Datadog go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Datadog

Given the investment horizon of 90 days Spyre Therapeutics is expected to generate 2.19 times more return on investment than Datadog. However, Spyre Therapeutics is 2.19 times more volatile than Datadog. It trades about 0.09 of its potential returns per unit of risk. Datadog is currently generating about 0.06 per unit of risk. If you would invest  1,050  in Spyre Therapeutics on September 14, 2024 and sell it today you would earn a total of  1,362  from holding Spyre Therapeutics or generate 129.71% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Spyre Therapeutics  vs.  Datadog

 Performance 
       Timeline  
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Datadog 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Datadog are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly abnormal basic indicators, Datadog reported solid returns over the last few months and may actually be approaching a breakup point.

Spyre Therapeutics and Datadog Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Spyre Therapeutics and Datadog

The main advantage of trading using opposite Spyre Therapeutics and Datadog positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Datadog can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Datadog will offset losses from the drop in Datadog's long position.
The idea behind Spyre Therapeutics and Datadog pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years